Raymond James & Associates’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.16M | Buy |
46,590
+14,640
| +46% | +$678K | ﹤0.01% | 2174 |
|
|
2024
Q2 | $1.04M | Buy |
31,950
+4,401
| +16% | +$143K | ﹤0.01% | 2585 |
|
|
2024
Q1 | $694K | Buy |
+27,549
| New | +$694K | ﹤0.01% | 2828 |
|
|
2022
Q4 | – | Sell |
-33,149
| Closed | -$850K | – | 3798 |
|
|
2022
Q3 | $850K | Buy |
33,149
+951
| +3% | +$24.4K | ﹤0.01% | 2504 |
|
|
2022
Q2 | $766K | Buy |
+32,198
| New | +$766K | ﹤0.01% | 2621 |
|
|
2021
Q1 | – | Sell |
-70,264
| Closed | -$1.84M | – | 3841 |
|
|
2020
Q4 | $1.84M | Sell |
70,264
-8,902
| -11% | -$233K | ﹤0.01% | 1930 |
|
|
2020
Q3 | $1.38M | Sell |
79,166
-8,665
| -10% | -$151K | ﹤0.01% | 1981 |
|
|
2020
Q2 | $1.48M | Sell |
87,831
-23,701
| -21% | -$399K | ﹤0.01% | 1902 |
|
|
2020
Q1 | $1.33M | Sell |
111,532
-86,132
| -44% | -$1.02M | ﹤0.01% | 1809 |
|
|
2019
Q4 | $2.39M | Buy |
197,664
+28,807
| +17% | +$349K | ﹤0.01% | 1718 |
|
|
2019
Q3 | $2.39M | Sell |
168,857
-5,402
| -3% | -$76.4K | ﹤0.01% | 1670 |
|
|
2019
Q2 | $1.94M | Buy |
174,259
+48,478
| +39% | +$541K | ﹤0.01% | 1820 |
|
|
2019
Q1 | $1.48M | Sell |
125,781
-56,739
| -31% | -$666K | ﹤0.01% | 1964 |
|
|
2018
Q4 | $2.44M | Buy |
182,520
+113,543
| +165% | +$1.52M | ﹤0.01% | 1527 |
|
|
2018
Q3 | $967K | Buy |
68,977
+19,307
| +39% | +$271K | ﹤0.01% | 2279 |
|
|
2018
Q2 | $781K | Buy |
49,670
+8,302
| +20% | +$131K | ﹤0.01% | 2364 |
|
|
2018
Q1 | $681K | Buy |
41,368
+1,505
| +4% | +$24.8K | ﹤0.01% | 2372 |
|
|
2017
Q4 | $720K | Sell |
39,863
-54,885
| -58% | -$991K | ﹤0.01% | 2310 |
|
|
2017
Q3 | $1.83M | Buy |
94,748
+6,720
| +8% | +$130K | ﹤0.01% | 1707 |
|
|
2017
Q2 | $1.04M | Buy |
88,028
+42,628
| +94% | +$503K | ﹤0.01% | 2002 |
|
|
2017
Q1 | $498K | Buy |
+45,400
| New | +$498K | ﹤0.01% | 2374 |
|